Information  X 
Enter a valid email address

Voyager Life PLC (VOY)

  Print   

Thursday 10 February, 2022

Voyager Life PLC

Launch of voyagerCann

RNS Number : 2238B
Voyager Life PLC
10 February 2022
 

 

 

10 February 2022

 

Voyager Life plc

 

("Voyager" or the "Company") 

 

Launch of voyagerCann

 

Voyager, the health and wellness company supplying high-quality Cannabidiol (CBD), hemp seed oil and hemp-related products , is pleased to announce the launch of voyagerCann, its new bespoke skincare product creation and development division.

 

On 20 December 2021, Voyager announced the acquisition of Cannafull's brands and assets including its associated brand Ascend Skincare following the liquidation of Cannafull's parent company.  Since then, Voyager has worked to re-establish trading in the business and is in the process of contacting Cannafull's customers and other potential customers offering a full turn-key service for the development and launch of new CBD skincare products.  These include:

 

· Product formulations

· White label solution

· Manufacturing services

· Product registration and regulatory compliance

· Labelling and packaging solutions

· Marketing and distribution

 

This new business-to-business service will operate as an integral part of Voyager's existing business and customers will therefore be able to benefit from the Company's experience and presence in the UK's CBD and plant-based wellness sector.  In particular, customers will have the opportunity to stock their products in Voyager's stores.  As part of this integration, and in recognition that the relaunched operations will offer a far wider range of services and products than before, the Company has re-branded the division voyagerCann.

 

Initial responses have been positive and voyagerCann is currently in discussions with customers on an order book that, if concluded, would have an aggregate value of over £50,000.

 

Voyager will be presenting its voyagerCann operations at the White Label Expo and the CBD Show, both of which take place in London, in March 2022 and April 2022 respectively.

 

Further details of voyagerCann's offering are set out at www.voyagercann.com .  voyagerCann products will be distinct to Voyager's existing range and will be bespoke for each customer.  voyagerCann already has over 20 existing product formulations, all of which can be adjusted to suit a customer's specific requirements.

 

Over the coming months, Voyager will also re-launch Ascend Skincare, a multi award-winning luxury skincare brand.  At the time of its acquisition, the brand had developed three botanical facial serums products, enhanced with natural, hemp-derived CBD . Voyager plans to supplement this range with further products during 2022. Ascend Skincare has previously received several positive reviews including a gold medal in the 2021 Free From Skincare Awards and winning all chosen categories in the 2021 Natural Health Beauty Awards.  Further details on these plans will be announced in due course.

 

Nick Tulloch, Chief Executive Officer and Founder of Voyager, said: "In a little over a month since acquiring the business out of liquidation, our new bespoke skincare manufacturing and product creation division is now up and running and trading as voyagerCann.  Initial discussions with previous customers, along with new contacts, have been very encouraging and they have been impressed with the enhanced service that voyagerCann is now able to offer as part of Voyager.  Concluding manufacturing and product development contracts is a detailed and time-consuming process; however, with voyagerCann's initial prospective gross order book already in excess of £50,000 in value, I believe this indicates that our original purchase price of £9,000 represented very good value.  Attendance at two trade fairs this spring will give us further potential to meet and speak to many more prospective customers as we seek to become one of the leading developers of new CBD skincare products in the UK."

 

The Directors of the Company accept responsibility for the content of this announcement.

 

ENDS

 

Enquiries:

Voyager

Nick Tulloch -  [email protected]  / 01738 505 130

http://voyagerlife.uk

 

Cairn Financial Advisers LLP (AQSE Corporate Adviser)

Ludovico Lazzaretti or Liam Murray +44 (0) 20 72130 880

 

Notes to Editors:

 

About Voyager

Voyager was founded in 2020 and is based in Perth, Scotland.  The Company's primary objective is the formulation and supply of high quality CBD and hemp seed oil products although it also produces several other complementary products, the majority of which are manufactured from the hemp plant.  Its product categories include a pet range which has rapidly developed into one of the Company's best sellers.  The Company sells online, through third party stores and in its own stores which are located in St Andrews, Edinburgh and Dundee.  Voyager products are currently available from Cornwall to Shetland in over 100 online and brick-and-mortar outlets.

 

The Company's philosophy of plant-based health and wellness is embodied in its mission statement and hashtag of "Choose you". With an experienced team and a product line created in line with the UK's regulatory regime, Voyager aims to become the trusted brand in this increasingly popular health and wellness space.

 

Through Voyager's bespoke skincare product creation and development division , voyagerCann , the Company also offers a full turnkey service to other CBD and cosmetics companies assisting them in developing and launching new products.

 

Website and social media links:

Voyager:

https://voyagercbd.com/

https://www.instagram.com/voyagercbd/

https://twitter.com/voyagercbd

https://www.linkedin.com/company/voyager-cbd/

https://www.facebook.com/voyagercbd/

 

voyagerCann:

https://voyagercann.com/

https://www.instagram.com/voyagercann /

https://twitter.com/voyagercann /

https://www.linkedin.com/company/voyagercann /

https://www.facebook.com/voyagercann /

 

Forward Looking Statements

These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not a guarantee of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. The Company cautions security holders and prospective security holders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances, or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXUPUUUPUPPPGB

a d v e r t i s e m e n t